Children's cancer research is an established academic strength in Newcastle, encompassing major research areas aimed at improving cure rates in leukaemia and neuroblastoma.
Major research themes
Our major research goals are:
- to develop a better understanding of the biological basis of childhood cancer development and response to treatment
- to translate these findings into improved therapies
Our central research themes are:
- Optimisation and individualistion of therapy according to host and disease characteristics, through:
- Improved molecular classification of childhood cancers, leading to the incorporation of prognostic and predictive biomarkers into treatment selection strategies.
- Optimisation of chemotherapeutic approaches through an improved knowledge of factors influencing drug disposition and metabolism
- Development of novel treatments, by:
- Identification of novel targets, pre-clinical drug development and advancing promising new therapies to early clinical trials
The CCRG encompasses over 80 researchers supporting the advancement of childhood cancer research. Our major disease interests are in:
- Leukaemia and lymphoma
- Paediatric nervous system tumours - brain tumours and neuroblastoma
Our areas of specific expertise include:
- Genomics and bioinformatics
- Biomarker discovery and development
- Drug target identification
- Stem cell biology
- Retinoid biology and therapies
- Drug development and delivery
- Paediatric pharmacology
- Molecular diagnostics and pathology review
- Early and late-phase clinical trials
The CCRG brings together Principal Investigators from across the Faculty of Medicine at Newcastle University, who lead programmes of research into paediatric cancers, including non-clinical scientists, clinician scientists and clinical researchers.
Research within the CCRG is intimately linked to the clinical teams at the Great North Children’s Hospital (GNCH), and many CCRG members hold joint or honorary appointments between Newcastle University and the GNCH. The group has strong links to national and international clinical trials organisations and coordinating groups for childhood cancer, and a network of worldwide collaborators.
We are committed to developing the childhood cancer researchers of the future, and host a series of post-graduate research students (at Masters or PhD level), including Clinical Training Fellows studying for higher degrees (MD or PhD) within their clinical training at the GNCH.
Our research training schemes for clinical academics are fully integrated within the NIHR scheme offered within the Faculty of Medicine, and provide opportunities for initial research experience (inter-calated Masters in Research for Newcastle medical students or the Academic Foundation Programme (AFP) for newly-qualified clinicians), higher-degree training (Academic Clinical Fellowships (ACF) or other national training fellowships), and early-stage academic career development (Academic Clinical Lecturers (ACL)).
Non-clinical post-doctoral scientists are supported in their development towards more independent roles, through mechanisms such as applications for internal and external fellowships.
Impact and engagement
CCRG members play major roles in developing treatments and policy for childhood cancers worldwide, through their leading roles and involvements in the national and international coordinating groups responsible for developing research and clinical trials, including:
- UK Children’s Cancer and Leukaemia Group (CCLG) special interest groups.
- National Cancer Research Institute (NCRI) Childhood Cancer and Leukaemia Clinical Study Group disease working groups.
- International Society for Paediatric Oncology (SIOP) disease working groups.
- Innovative Therapies for Children with Cancer (ITCC): European coordinating group for drug development and early-phase trials.
Newcastle is the UK national coordinating centre for childhood cancer biobanking, pharmacology studies and molecular diagnostics and pathology review for medulloblastoma clinical trials.
Dr Christopher Bacon
Senior Lecturer and Honorary Consultant in Haematopathology
Telephone: +44 (0) 191 208 4404
Professor Simon Bailey
Professor of Paediatric Neuro-Oncology
Telephone: 0191 29825395
Professor Alan Boddy
Professor of Cancer Pharmacology
Telephone: +44 (0) 191 208 4412
Professor Steven Clifford
Prof of Molecular Paediatric Oncology
Telephone: +44 (0) 191 208 2229
Professor Andy Hall
Associate Dean of Bioresources
Telephone: +44 (0) 191 208 7161
Professor Olaf Heidenreich
Professor of Molecular Haematology
Telephone: ++44 191-246-4365
Dr Julie Irving
Reader in Experimental Haematology
Telephone: +44 (0) 191 208 4369
Professor John Lunec
Gillespie Prof of Molecular Oncology
Telephone: +44 (0) 191 208 4420
Professor Anthony Moorman
Professor of Genetic Epidemiology
Telephone: +44 (0) 191 208 2238
Dr Vikki Rand
Bloodwise Senior Bennett Fellow
Telephone: +44 (0) 191 208 4437
Dr Christopher Redfern
Reader in Retinoid Molecular Biology
Telephone: +44 (0) 191 208 4416
Professor Deborah Tweddle
Professor of Paediatric Oncology
Telephone: +44 (0) 191 208 2230
Dr Britta Vormoor
Associate Clinical Lecturer
Telephone: +44 (0) 191 208 4386
Professor Josef Vormoor
Sir James Spence Prof of Child Health
Telephone: +44 (0) 191 282 1357
Dr Daniel Williamson
Newcastle University Research Fellow
Dr Katrina Wood
Associate Clinical Lecturer